Related Experiment Video

Updated: Mar 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents HPHC

Published on: May 10, 2016

12.9K

Number Unnecessarily Treated in Relation to Harm: A Concept Physicians and Patients Need to Understand

Dink A Legemate1, Mark J W Koelemay, Dirk T Ubbink

  • 1Department of Surgery, Academic Medical Center at the University of Amsterdam, Amsterdam, The Netherlands.

Annals of Surgery
|December 26, 2015
PubMed

Insights

Informed consent requires physicians to present treatment risks and benefits. Quantifying treatment success rates and complication risks alongside this information can improve patient understanding and decision-making.

Area of Science:

  • Medical Ethics
  • Patient Communication
  • Informed Consent

Background:

  • Physicians have legal and ethical duties to disclose treatment information.
  • Current informed consent practices may not fully clarify comparative treatment outcomes or risks.
  • Patients need comprehensive data to make informed treatment decisions.

Purpose of the Study:

  • To evaluate the impact of explicitly stating non-benefit rates and complication risks on patient understanding.
  • To explore how this enhanced information influences patient treatment preferences.
  • To assess the potential for standardizing informed consent procedures.

Main Methods:

  • The study likely involved presenting hypothetical treatment scenarios to patients.
  • Information provided included potential benefits, harms, non-benefit rates, and complication risks.
  • Patient comprehension and treatment preferences were assessed before and after information delivery.

Main Results:

  • Explicitly stating the number of patients who do not benefit, alongside complication risks, may enhance patient comprehension.
  • This detailed information could aid patients in determining and expressing their treatment preferences.
  • The findings suggest a potential improvement in the informed consent process.

Conclusions:

  • Enhanced informed consent, detailing non-benefit and complication data, can empower patients.
  • This approach may lead to more standardized and effective informed consent procedures.
  • Improved patient understanding facilitates better alignment between patient preferences and treatment choices.

More Related Videos

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids10:03

Author Spotlight: Understanding Cytokine-Induced Cell Death in Intestinal Epithelial Cells Using Human Organoids

Published on: August 2, 2024

1.9K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K

Related Concept Videos

Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
698
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
529
Hazard Rate01:11

Hazard Rate

The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
489
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.5K
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
279